BACKGROUND: Neurodevelopmental and functional impairments are among the most consequential morbidities for survivors of ...

First-ever mini-Heart models will be created from hypoplastic left heart syndrome (HLHS) patient stem cells, enabling personalized insights into their causes and treatmentsPartnership aims to ...

Longeveron announces full enrollment in Phase 2b trial of laromestrocel for Hypoplastic Left Heart Syndrome, anticipating results in 2026.

First-ever mini-Heart models will be created from hypoplastic left heart syndrome (HLHS) patient stem cells, enabling personalized insights into their causes and treatments Partnership aims to ...

Micah Clayborne was diagnosed with Danon disease, a rare condition, after complaining of chest pains. He needed a heart ...

Nataliya Agafonova Nataliya Agafonova, M.D., Chief Medical Officer, Longeveron Top-line trial results are anticipated in the third quarter of 2026, after the final follow-up at 12 ...

About Hypoplastic Left Heart Syndrome (HLHS) HLHS is a congenital birth defect in which the left ventricle (one of the pumping chambers of the heart) is either severely underdeveloped or missing.

Takotsubo cardiomyopathy, or broken heart syndrome, is a rare stress-induced heart condition that is prevalent in women, but a recent study showed it may be deadly for men.

This new AI heart disease detector can’t be beat. S (SHD) refers to defects in the heart’s valves, wall or chambers that are present at birth or develop ...

BACKGROUND: Fontan circulatory failure (FCF) is a chronic state in palliated single ventricle heart disease with high morbidity and mortality rates, including heart failure, multisystem end-organ ...

Deaths from heart attacks dropped by 90%, but other heart disease risks are on the rise. Here's what to know.